Home › GLP-1 Medications › Novo Nordisk
Latest three-month snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each model brings the brand up in recommendation answers.
| model | share of voice | answers |
|---|---|---|
| ChatGPT | 88% | 21 of 24 |
| Claude | 100% | 24 of 24 |
| Gemini | 63% | 15 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 83% | 60 of 72 |
Recurring descriptions in the models' own words, grouped by theme.
“Because it is a generic, it contains the exact same active ingredient and is administered as a daily injection.”
“* **The Rybelsus Downside for Weight Loss:** Rybelsus is an oral tablet of semaglutide.”
“* **Rybelsus** is FDA-approved specifically for **improving blood sugar control and reducing cardiovascular risk in adults with Type 2 diabetes**.”
“If you have Type 2 Diabetes and have an intense aversion to needles, **Rybelsus (oral semaglutide)** is your target medication.”
“Mounjaro is a first-of-its-kind **dual GIP and GLP-1 receptor agonist**.”
“However, Rybelsus was also approved for cardiovascular risk reduction in adults with type 2 diabetes.”
“* **Rybelsus** is a daily pill that comes with very strict requirements: you must take it immediately upon waking with no more than 4 ounces of plain water, and you must wait at least 30 minutes before eating, drinking anything else, or taking other oral medications, or the drug ”
“Additionally, weekly injections are more convenient than Victoza's daily regimen, and both manufacturers offer copay saving cards that can dramatically lower your out-of-pocket costs.”
“* **Ozempic** is specifically FDA-approved to lower blood sugar in adults with type 2 diabetes and to reduce the risk of major cardiovascular events (like stroke or heart attack) in diabetics with established heart disease.”
“**Victoza** is approved for Type 2 diabetes, while **Saxenda** is approved for weight loss.”
598 exact quoted mentions in this snapshot, grouped by coded tone. Recent quotes are deduplicated and mixed across models.
“Though primarily a diabetes medication, Victoza suppresses appetite and slows digestion. Clinical studies show that patients taking the maximum diabetes dose (1.8 mg) lose an average of about 5% of their body weight (while its sibling drug,”
“FDA-approved brand-name drugs (Ozempic, Wegovy, Mounjaro, Zepbound) These went through rigorous clinical trials and FDA review, so their core efficacy/safety data is credible.”
“This is one of the most widely recognized GLP-1 medications. It is highly effective at lowering blood sugar and helping with weight loss. It is also strongly recommended for patients who have established heart disease, as it is FDA-approved”
“These FDA-approved alternatives include Wegovy, Saxenda, phentermine, and Contrave and are typically far less expensive out-of-pocket than GLP-1 injectables”
“**Generic liraglutide injection** (generic Victoza): This is the main lower-cost **GLP‑1–class** alternative worth checking. Unlike Trulicity, it is **daily** rather than weekly.”
“Saxenda can be worth it if you meet medical criteria, can tolerate a **daily injection**, and insurance makes the cost reasonable—but it is no longer usually the strongest-value GLP-1 option when weekly alternatives are covered.”
“Whether **Rybelsus** (oral semaglutide) is "worth it" depends entirely on your medical goals (managing diabetes vs. weight loss), your budget, and how you feel about needles and daily morning routines.”
“**Ozempic** (semaglutide)”
“"Same as Ozempic/Wegovy/Zepbound" or "generic semaglutide/tirzepatide."”
“However, unlike those medications, which are weekly injections, Rybelsus is a **once-daily pill**. It is FDA-approved to treat Type 2 Diabetes but is frequently prescribed off-label for weight loss.”
“**Do not choose Ozempic or Mounjaro solely because they are popular.** They contain the same active ingredients as Wegovy and Zepbound, respectively, but are branded and FDA-approved primarily for type 2 diabetes”
“Novo Nordisk (maker of Ozempic and Wegovy) has been hit with **multiple FDA warning letters in 2026** for misleading TV ads.”
“**Don't simply switch to Ozempic, Mounjaro, Trulicity, or Rybelsus assuming they'll be cheaper.** They may be better covered by a particular plan, but their cash prices are often not lower than generic liraglutide.”
“Unlike the only other major oral GLP-1, Rybelsus, which must be taken on an empty stomach with a tiny sip of water at least 30 minutes before eating or drinking”
“Rybelsus is approved for type 2 diabetes... patients taking Rybelsus 14 mg experienced an average body weight reduction of about 2.3 kg (~5 lbs) over 26 weeks — a much more modest result than the roughly 15% seen with Wegovy.”
Which competitors models suggest when shoppers ask for something cheaper.
93 of 598 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| goodrx.com | 17 |
| singlecare.com | 12 |
| healio.com | 6 |
| tevapharm.com | 6 |
| sesamecare.com | 5 |
| noom.com | 4 |
| eden.health | 4 |
| forbes.com | 4 |
| buzzrx.com | 4 |
| fda.gov | 3 |
| primetherapeutics.com | 3 |
| drugs.com | 3 |
Stores and sites models name as places to buy this brand.
| retailer | mentions |
|---|---|
| GoodRx | 5 |
| NovoCare | 3 |
| SingleCare | 2 |
| Publix | 1 |
| Publix Pharmacy | 1 |
| NovoCare Pharmacy | 1 |
| large retailers | 1 |
| independent pharmacies | 1 |
| online providers | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.